Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 17 , ISSUE 4 ( August, 2013 ) > List of Articles


Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit

Prithwis Bhattacharyya, Jeetendra Gurung, Annie Bakorlin Khyriem, Amit Banik, Wihiwot Valarie Lyngdoh, Basabdatta Choudhury

Keywords : Acinetobacter baumannii, biofilm, multidrug resistant, Pseudomonas aeruginosa

Citation Information : Bhattacharyya P, Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med 2013; 17 (4):214-218.

DOI: 10.4103/0972-5229.118416

License: CC BY-ND 3.0

Published Online: 01-07-2014

Copyright Statement:  Copyright © 2013; The Author(s).


Background and Aims: Given choice, bacteria prefer a community-based, surface-bound colony to an individual existence. The inclination for bacteria to become surface bound is so ubiquitous in diverse ecosystems that it suggests a strong survival strategy and selective advantage for surface dwellers over their free-ranging counterparts. Virtually any surface, biotic or abiotic (animal, mineral, or vegetable) is suitable for bacterial colonization and biofilm formation. Thus, a biofilm is "a functional consortium of microorganisms organized within an extensive exopolymeric matrix." Materials and Methods: The present study was undertaken to detect biofilm production from the repertoire stocks of Acinetobacter baumannii (A. baumannii) and Pseudomonas aeruginosa (P. aeruginosa) obtained from clinical specimens. The tube method was performed to qualitatively detect biofilm production. Results: A total of 109 isolates of both organisms were included in the study, out of which 42% (46/109) isolates showed biofilm detection. Among the biofilm producers, 57% of P. aeruginosa and 73% of A. baumannii showed multidrug resistance (MDR) pattern which was statistically significant in comparison to nonbiofilm producers (P < 0.001). Conclusion: To the best of our knowledge, this is the only study to have tested the biofilm production in both P. aeruginosa and A. baumannii in a single study. Biofilm production and MDR pattern were found to be significantly higher in A. baumannii than P. aeruginosa. Antibiotic resistance was significantly higher among biofilm producing P. aeruginosa than non producers. Similarly, antibiotic resistance was significantly higher among biofilm producing A. baumannii than non producers.

PDF Share
  1. Dunne WM Jr. Bacterial adhesion: Seen any good biofilms lately? Clin Microbiol Rev 2002;15:155-66.
  2. Donlan RM. Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002;8:881-90.
  3. Donlan RM. Biofilm formation: A clinically relevant microbiological process. Clin Infect Dis 2001;33:1387-92.
  4. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-93.
  5. Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S, et al. Correlation between biofilm production and multiple drug resistance in Imipenem resistant clinical isolates of Acinetobacter baumanii. Indian J Med Microbiol 2008;26:333-7.
  6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 19 th informational supplement, M100-S19. Wayne: CLSI, 2009;29:44-7.
  7. Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime producing strains of staphylococcus epidermidis to smooth surfaces. Infect Immun 1982;37:318-26.
  8. Stepanovic S, Vukovic D, Dakic I, Savic B, Vlahovic MS. A modified microtiter-plate test for quantification of Staphylococcus biofilm formation. J Microbiol Methods 2000;40:175-9.
  9. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: Multidrug resistant Acinetobacter baumannii. Nat Rev Microbiol 2007;5:939-51.
  10. Navon-Venezia S, Ben-Ami R, Carmeli Y. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the health care setting. Curr Opin Infect Dis 2005;18:306-13.
  11. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010;35:322-32.
  12. Costeron JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999;284:1318-22.
  13. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001;45:999-1007.
  14. Rodriguez-Bano J, Marti S, Soto S, Fernandez-Cuenca F, Cisneros JM, Pachon J, et al. Spanish Group for the Study of Nosocomial Infections (GEIH). Biofilm formation in Acinetobacter baumannii: Associated features snd clinical implications. Clin Microbiol Infect 2008;14:276-8.
  15. Marti S, Rodriguez-Bano J, Catel-Ferreira M, Jouenne T, Vila J, Seifert H, et al. Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species. BMC Res Notes 2011;4:5.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.